GENE - CHEMICAL INTERACTIONS REPORT
|
|
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
[AKR1B8 protein co-treated with NADP] affects the oxidation of 1-hexanol
[AKR1B8 protein co-treated with NADP] affects the oxidation of 1-indanol
[AKR1B8 protein co-treated with NADP] affects the oxidation of n-decyl alcohol
[AKR1B8 protein co-treated with NADP] affects the oxidation of 1-nonanol
[AKR1B8 protein co-treated with NADP] affects the oxidation of Benzyl Alcohol
[AKR1B8 protein co-treated with NADP] affects the oxidation of Nicotinyl Alcohol
[AKR1B8 protein co-treated with NADP] affects the reduction of 16-ketoestrone
[AKR1B8 protein co-treated with NADP] affects the reduction of 1-phenyl-1,2-propanedione
[AKR1B8 protein co-treated with NADP] affects the reduction of 21-dehydrocortisol
[AKR1B8 protein co-treated with NADP] affects the reduction of 2,3-pentanedione
[AKR1B8 protein co-treated with NADP] affects the reduction of 2,3-hexanedione
[AKR1B8 protein co-treated with NADP] affects the reduction of 2,4-decadienal
[AKR1B8 protein co-treated with NADP] affects the reduction of 2,4-nonadienal
[AKR1B8 protein co-treated with NADP] affects the reduction of 2-nonenal
[AKR1B8 protein co-treated with NADP] affects the reduction of 2-hexenal
[AKR1B8 protein co-treated with NADP] affects the reduction of 3-deoxyglucosone
[AKR1B8 protein co-treated with NADP] affects the reduction of 4-hydroxy-2-nonenal
[AKR1B8 protein co-treated with NADP] affects the reduction of 4-nitrobenzaldehyde
[AKR1B8 protein co-treated with NADP] affects the reduction of Acrolein
[AKR1B8 protein co-treated with NADP] affects the reduction of benzaldehyde
[AKR1B8 protein co-treated with NADP] affects the reduction of Diacetyl
[AKR1B8 protein co-treated with NADP] affects the reduction of glycolaldehyde
[AKR1B8 protein co-treated with NADP] affects the reduction of Glyoxal
[AKR1B8 protein co-treated with NADP] affects the reduction of butyraldehyde
[AKR1B8 protein co-treated with NADP] affects the reduction of Isatin
[AKR1B8 protein co-treated with NADP] affects the reduction of Phenylglyoxal
[AKR1B8 protein co-treated with NADP] affects the reduction of Pyruvaldehyde



